Accurately and Efficiently Monitor the Performance of HbA1c Assays

The American Diabetes Association, International Diabetes Federation and European Association for the Study of Diabetes consider HbA1c a more reliable indicator of long-term diabetic control than blood glucose.

In order to have confidence in the patient results reported good quality control is essential. A good control should be consistent over repeated analysis; have a good working stability and a long shelf life Randox can provide just this.

The new HbA1c control from Randox is made from 100% human whole blood and is designed to accurately and efficiently monitor the performance of HbA1c assays.

Accurately assigned % HbA1c target values and ranges with corresponding Total Haemoglobin and HbA1c concentration values are provided for all major systems and methods including HPLC.

The HbA1c controls are lyophilised providing enhanced shelf life and stability. An extended shelf life reduces the frequency of lot crossovers and allows users to sequester and use the same lot of control over a number of years significantly reducing reagent costs. A working stability of 28 days at 2-8oC minimises waste and saves money.

To complement the HbA1c controls an HbA1c linearity set is also available designed to verify the linearity of HbA1c assays across the clinically important range. Four clinically significant levels are provided eliminating the requirement for very low and or very high patient samples normally used to assess linearity. Like the HbA1c controls the linearity set is suitable for use on all platforms and contains accurately assigned values for the most common analysers and methods.